Proteome Sciences plc provided revenue guidance for 2013. For the year, revenue expected to show a significant increase over 2012 resulting from the strong performance across core activities.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.43 GBX | -4.72% | -12.05% | -24.28% |
May. 16 | Proteome Sciences promises AGM return to growth in 2024 | AN |
May. 16 | AIM WINNERS & LOSERS: Proteome Sciences eyes return to growth in 2024 | AN |
1st Jan change | Capi. | |
---|---|---|
-24.28% | 12.91M | |
-5.56% | 181B | |
-0.11% | 108B | |
-6.17% | 66.12B | |
+2.64% | 50.65B | |
+6.58% | 43.11B | |
+2.38% | 41.3B | |
+21.98% | 31.6B | |
+16.05% | 25.03B | |
-5.81% | 24.16B |
- Stock Market
- Equities
- PRM Stock
- News Proteome Sciences plc
- Proteome Sciences plc Provides Revenue Guidance for 2013